One reason for this difference might be that both ADA and ETN can suppress the immune system by inhibiting TNF‐α, which might influence susceptibility to infections and ultimately contribute to the fact that the incidence of adverse events has remained unchanged between ADA and ETN.43 This evidence concerns the gene ADA and infection.